Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.38 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31664450 | 0.87 | SMN1; SMN2 (0.42) | SMN1; SMN2TDP1PLA2G1BATG4BFKBP1A | |
| SCHEMBL31664414 | 0.81 | SMN1; SMN2 (0.45) | SMN1; SMN2TDP1PLA2G1BATG4BFKBP1A | |
| SCHEMBL31664399 | 0.80 | HIF1A (0.47) | MAPTESR1HIF1AACACB | |
| SCHEMBL25454107 | 0.78 | MEN1 (0.42) | MAPTESR1HIF1AACHEKDM4E | |
| SCHEMBL31664413 | 0.78 | SMN1; SMN2 (0.41) | SMN1; SMN2TDP1PLA2G1BATG4BFKBP1A | |
| SCHEMBL31664434 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2TDP1PLA2G1BATG4BFKBP1A | |
| SCHEMBL16672984 | 0.74 | ESR1 (0.41) | SMN1; SMN2ESR1ACHEKDM4E | |
| SCHEMBL19122983 | 0.73 | SMN1; SMN2 (0.59) | SMN1; SMN2TDP1MAPTACACBKMT2A | |
| SCHEMBL31664418 | 0.73 | CASP1 (0.43) | SMN1; SMN2TDP1PLA2G1BATG4BFKBP1A | |
| SCHEMBL3720465 | 0.72 | SMN1; SMN2 (0.46) | SMN1; SMN2TDP1MAPTESR1ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | BBOX1, NISCH, TAS2R4 | SMN1; SMN2 2236/4885TDP1 2932/4885PLA2G1B 3409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.